$SRPT News 7 gut checks before the stock market's opening

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2013 at 7:05 PM

$SRPT News

7 gut checks before the stock market's opening bell 7:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 6:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 11:10 a.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 2:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 4:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 10:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 8:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 8:49 a.m. March 14, 2013 - The Trading Deck
Caesars, Zynga among charts to watch today 1:50 p.m. Feb. 28, 2013 - The Trading Deck
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Dow, Nasdaq return to scene of the breakdown 12:02 p.m. Nov. 27, 2012 - Michael Ashbaugh
Dow, Nasdaq return to scene of the breakdown 11:46 a.m. Nov. 27, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 12:20 p.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 11:46 a.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 12:09 p.m. Nov. 6, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 11:34 a.m. Nov. 6, 2012 - Michael Ashbaugh
Nasdaq retesting the 200-day moving average 11:10 a.m. Oct. 25, 2012 - Michael Ashbaugh

Amarin, Sarepta And Vanda: Teachable Moments In Biotech 10:23 a.m. Nov. 17, 2013 - Seeking Alpha
Insider Trading Alert - TYL, OPK, SRPT, HAL And MLNX Traded By Insiders 11:45 a.m. Nov. 15, 2013 - TheStreet.com
Today's Perilous Reversal Stock: Sarepta Therapeutics (SRPT) 10:10 a.m. Nov. 15, 2013 - TheStreet.com
How to Trade Sarepta After the FDA Setback 6:00 a.m. Nov. 14, 2013 - TheStreet.com
Sarepta Therapeutics: No Longer A Momentum Play, But Long-Term Value Remains 3:30 a.m. Nov. 14, 2013 - Seeking Alpha
Analysts: BlackBerry Fundamentals Are Not Improving and 3 More Research Notes to Read 2:44 p.m. Nov. 13, 2013 - Wall St. Cheat Sheet
Sarepta Down on FDA's Response - Analyst Blog 12:10 p.m. Nov. 13, 2013 - Zacks.com
UPDATE: Deutsche Bank Downgrades Sarepta Therapeutics Following FDA Announcement That NDA Filing is Premature 9:17 a.m. Nov. 13, 2013 - benzinga.com
A Post-Mortem on Sarepta's Epic Explosion, Mea Culpa Included 6:47 a.m. Nov. 13, 2013 - TheStreet.com
VNDA Stock Nearly Doubles in One Day 3:49 a.m. Nov. 13, 2013 - InvestorPlace.com
Why Shares of SRPT Stock Sank 65% 3:09 a.m. Nov. 13, 2013 - InvestorPlace.com
Why Shares of SRPT Stock Sank 65% 3:09 a.m. Nov. 13, 2013 - InvestorPlace.com
Searching for Clarity 4:31 p.m. Nov. 12, 2013 - RealMoney.com
FDA Wants More Testing of Muscular-Dystrophy Drug 4:23 p.m. Nov. 12, 2013 - WSJ.com
Stocks Slip on Lackluster Earnings as Fed's Fisher Signals Pullback 4:21 p.m. Nov. 12, 2013 - TheStreet.com
Sarepta Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 2:45 p.m. Nov. 12, 2013 - Seeking Alpha
Analysts: Macy’s Estimates Are Overly Optimistic and 3 More Research Notes to Look Through 1:29 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Signs of a Turning Point? 1:20 p.m. Nov. 12, 2013 - RealMoney.com
Sarepta Therapeutics Plunges On Negative FDA Report 1:20 p.m. Nov. 12, 2013 - Investors Business Daily
Sarepta Therapeutics: FDA Considers NDA Filing for Eteplirsen "Premature" 11:59 a.m. Nov. 12, 2013 - benzinga.com

Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws 2:58 p.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT 12:03 p.m. Nov. 13, 2013 - PR Newswire
Insider Trading Research for Micron, Hertz, Annaly Capital Management, Sarepta Therapeutics, Rackspace Hosting, and Tesla Motors 8:55 a.m. Nov. 13, 2013 - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. 3:00 p.m. Nov. 12, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 7:01 a.m. Nov. 12, 2013 - Marketwire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013 8:30 a.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 9:05 a.m. Oct. 21, 2013 - PR Newswire
Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With Duchenne Muscular Dystrophy 8:31 a.m. Oct. 17, 2013 - Marketwire
Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on October 17, 2013 4:30 p.m. Oct. 10, 2013 - Marketwire
Critical Alerts For Coca-Cola, Biogen Idec, Hewlett-Packard, Yum! Brands, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Oct. 8, 2013 - PR Newswire
Cellular Biomedicine Has Multiple Near-Term Catalysts 10:27 a.m. Oct. 3, 2013 - ACCESSWIRE
Sarepta Therapeutics Introduces Online Resource Center on Exon Skipping for the Duchenne Muscular Dystrophy Community 8:31 a.m. Oct. 2, 2013 - Marketwire
Sarepta Therapeutics Announces Eteplirsen Demonstrates Continued Stability on Walking Test Through 96 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy 8:30 a.m. Sept. 26, 2013 - Marketwire
Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:52 a.m. Sept. 25, 2013 - PR Newswire
SRPT, FB, CRUS and OMER added to NASDAQ Active Stock Watch List at GSR 9:02 a.m. Sept. 24, 2013 - ACCESSWIRE
Insider Trading Research for Sarepta Therapeutics, QUALCOMM, Sirius XM Radio, Yahoo, Annaly Capital Management, and Bank of America 8:55 a.m. Sept. 23, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on CYCC, RNA, RVP and SRPT 8:40 a.m. Sept. 23, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR Sets New Sales Record, Eyes Market Expansion

FFR Breaks New Ground With Record Sales Something big's brewing at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR), and it's causing quite the ripple. Picture this: 351 devices shipped in October alone. That's a hill-climbing record for this newbie on the U.S. stock scene. February was their starting line, and they've zoomed past 1,000 units in cumulative sales, chalking up...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

TikTok-Coda: A New Era for Digital Commerce

Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...

HashKey and RD Tech Partner for RDUSD Expansion

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

Orthocell's Remplir™ Hits Record U.S. Sales in October

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Context Labs Unveils AI Distillery for Enterprises

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Navigating the Maze of Required Minimum Distributions

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Abbott's SonicForce Impresses in Crucial Clinical Trial

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

CPC's Rigorous Self-Governance Balances Power Effectively

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...